Focusing in New Role at NuGen Medical Devices Inc.

TORONTO, ON / ACCESSWIRE / February 27, 2023 / Buzbuzian Capital Corp. 'BCC' (the "Company", is pleased to announce that Richard Buzbuzian has resigned from the Advisory Board of Drone Delivery Canada Corp. ‘DDC' (TSXV - FLT) and as its Head of Capital Markets to focus in his new role as President and CEO of NuGen Medical Devices Inc. ‘NuGen' (TSXV - NGMD).

NuGen's InsuJet™ is an innovative needle-free injector that is a non-invasive way to administer insulin. Its safer with the absence of needles and it has faster results in the uptake of insulin compared to syringes. It is also very appealing for adults and children and is cost effect, less than 1 euro a day. The total addressable market (TAM) is very large and InsuJet™ is approved for sale in 42 countries.

"Its now time to monetize InsuJet™ and with my resignation from DDC, I have devoted myself to the success of NuGen and I am committed to delivering shareholder's results." commented Richard Buzbuzian, President and CEO of NuGen Medical Devices. In 25 years of business, I have never seen an opportunity as special and simply as big as NuGen. InsuJet™ an incredible product that will improve life for millions of diabetics worldwide."

Previous to his role with NuGen, from 2015 to 2019 Mr. Buzbuzian was the former President of Drone Delivery Canada Corp. (TSXV: FLT), which he cofounded, took public, and raised over Cdn$120M in equity financings achieving market capitalization in excess of $550M.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

About Buzbuzian Capital Corp.

Buzbuzian Capital Corporation is a Canadian family office managing an investment portfolio of public and pre-IPO companies in the technology sector as well as a variety of special situations

For further information, please visit:

Website: www.buzbuzian.com

For further information, please contact:

Richard Buzbuzian
President & CEO
(647) 501-3290
richard@buzbuzian.com

Notice Regarding Forward-Looking Information:

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

SOURCE: NuGen Medical Devices